BHEL Appoints S M Ramanathan as Director (R&D)

By By Rediff Money Desk, New Delhi
Apr 30, 2025 20:10
BHEL has appointed S M Ramanathan as Director (Engineering, Research & Development), as approved by the Board of Directors and the Appointment Committee of the Cabinet.
New Delhi, Apr 30 (PTI) State-owned BHEL on Wednesday said the board has approved the appointment of S M Ramanathan as its Director (Engineering, Research & Development).

In a regulatory filing, BHEL said it has received a communication from the Ministry of Heavy Industries, informing that the Appointment Committee of the Cabinet (ACC) has approved the appointment of S M Ramanathan, Executive Director, BHEL, to the post.

"The proposal for induction of S M Ramanathan to the post of Director (Engineering, Research & Development) BHEL has been approved by the Board of Directors of Company in its meeting held today," BHEL said.
Source: PTI
Read More On:
bhels m ramanathandirectorengineeringresearch & development
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.

You May Like To Read

MORE NEWS

Coal Mining: Panel Urges Faster Green Clearances

Parliamentary panel urges faster environmental & forest clearances for coal mining...

DCM Shriram & Bayer Crop Science Collaboration

DCM Shriram and Bayer Crop Science partner to explore agricultural opportunities in...

Silver Price Soars to Rs 1.92 Lakh/kg on Global...

Silver prices surge Rs 11,500 to Rs 1.92 lakh/kg in Delhi amid strong global cues. Gold...

Urea Fixed Costs to Rise for Manufacturers

Govt plans to raise fixed costs for urea makers by year-end. Decision expected soon,...

Bullion Rates Today: Gold & Silver Prices

Check today''s closing bullion rates in Bengaluru. Gold (22K & 24K) prices per gram and...

Bank of India Raises Rs 2,500 Cr via Tier II Bonds

Bank of India (BoI) raised Rs 2,500 crore through Basel III-compliant Tier II bonds at...

Cipla Launches Obesity & Diabetes Drug Yurpeak

Cipla launches Yurpeak (tirzepatide), a weekly injectable for obesity and type-2...

Sebi Eases KYC for NRIs, Removes Physical Presence

Sebi relaxes re-KYC for NRIs, removing physical presence requirement for digital...

OPTCL & NABARD Pact: Power Boost in Odisha

OPTCL and NABARD sign MoU for power infrastructure development in Odisha. NABARD...

CG Power Turnaround: Srinivasan's Book

N Srinivasan's book chronicles CG Power's revival from bankruptcy to a USD 10 billion...

Read More »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2025 Rediff.com